Filippi M, Danesi R, Derfuss T, Duddy M, et al. Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis. J Neurol 2021 Oct 9. pii: 10.1007/s00415-021-10836.
PMID: 34626224